Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 3
2004 2
2005 5
2006 7
2007 7
2008 4
2009 7
2010 6
2011 16
2012 6
2013 4
2014 5
2015 1
2016 3
2017 6
2018 8
2019 6
2020 6
2021 7
2022 9
2023 7
2024 8
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Entinostat as a combinatorial therapeutic for rhabdomyosarcoma.
Chauhan S, Lian E, Habib I, Liu Q, Anders NM, Bugg MM, Federman NC, Reid JM, Stewart CF, Cates T, Michalek JE, Keller C. Chauhan S, et al. Among authors: michalek je. Sci Rep. 2024 Aug 15;14(1):18936. doi: 10.1038/s41598-024-66545-5. Sci Rep. 2024. PMID: 39147820 Free PMC article.
Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients.
Das D, Wang X, Chiu YC, Bouamar H, Sharkey FE, Lopera JE, Lai Z, Weintraub ST, Han X, Zou Y, Chen HH, Zeballos Torrez CR, Gu X, Cserhati M, Michalek JE, Halff GA, Chen Y, Zheng S, Cigarroa FG, Sun LZ. Das D, et al. Among authors: michalek je. J Natl Cancer Inst. 2024 Dec 1;116(12):1961-1978. doi: 10.1093/jnci/djae207. J Natl Cancer Inst. 2024. PMID: 39189979
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages.
Hung CN, Chen M, DeArmond DT, Chiu CH, Limboy CA, Tan X, Kusi M, Chou CW, Lin LL, Zhang Z, Wang CM, Chen CL, Mitsuya K, Osmulski PA, Gaczynska ME, Kirma NB, Vadlamudi RK, Gibbons DL, Warner S, Brenner AJ, Mahadevan D, Michalek JE, Huang TH, Taverna JA. Hung CN, et al. Among authors: michalek je. Cell Rep. 2023 Sep 26;42(9):113067. doi: 10.1016/j.celrep.2023.113067. Epub 2023 Sep 1. Cell Rep. 2023. PMID: 37659081 Free PMC article.
SMARCA4 biology in alveolar rhabdomyosarcoma.
Bharathy N, Cleary MM, Kim JA, Nagamori K, Crawford KA, Wang E, Saha D, Settelmeyer TP, Purohit R, Skopelitis D, Chang K, Doran JA, Kirschbaum CW, Bharathy S, Crews DW, Randolph ME, Karnezis AN, Hudson-Price L, Dhawan J, Michalek JE, Ciulli A, Vakoc CR, Keller C. Bharathy N, et al. Among authors: michalek je. Oncogene. 2022 Mar;41(11):1647-1656. doi: 10.1038/s41388-022-02205-0. Epub 2022 Jan 29. Oncogene. 2022. PMID: 35094009 Free PMC article.
Targeting S6K/NFκB/SQSTM1/Polθ signaling to suppress radiation resistance in prostate cancer.
Clark A, Villarreal MR, Huang SB, Jayamohan S, Rivas P, Hussain SS, Ybarra M, Osmulski P, Gaczynska ME, Shim EY, Smith T, Gupta YK, Yang X, Delma CR, Natarajan M, Lai Z, Wang LJ, Michalek JE, Higginson DS, Ikeno Y, Ha CS, Chen Y, Ghosh R, Kumar AP. Clark A, et al. Among authors: michalek je. Cancer Lett. 2024 Aug 10;597:217063. doi: 10.1016/j.canlet.2024.217063. Epub 2024 Jun 24. Cancer Lett. 2024. PMID: 38925361 Free article.
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma.
Randolph ME, Cleary MM, Bajwa Z, Svalina MN, Young MC, Mansoor A, Kaur P, Bult CJ, Goros MW, Michalek JE, Xiang S, Keck J, Krasnoperov V, Gill P, Keller C. Randolph ME, et al. Among authors: michalek je. PLoS One. 2017 Aug 17;12(8):e0183161. doi: 10.1371/journal.pone.0183161. eCollection 2017. PLoS One. 2017. PMID: 28817624 Free PMC article.
Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients.
Das D, Wang X, Chiu YC, Bouamar H, Sharkey FE, Lopera JE, Lai Z, Weintraub ST, Han X, Zou Y, Chen HH, Zeballos Torrez CR, Gu X, Cserhati M, Michalek JE, Halff GA, Chen Y, Zheng S, Cigarroa FG, Sun LZ. Das D, et al. Among authors: michalek je. medRxiv [Preprint]. 2024 Apr 30:2024.04.27.24306447. doi: 10.1101/2024.04.27.24306447. medRxiv. 2024. Update in: J Natl Cancer Inst. 2024 Dec 1;116(12):1961-1978. doi: 10.1093/jnci/djae207. PMID: 38746245 Free PMC article. Updated. Preprint.
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma.
Kim JA, Crawford KA, Spada PA, Martin LR, Zhang J, Wong R, Reid JM, Stewart CF, Frank TM, Liu Q, Michalek JE, Keller C. Kim JA, et al. Among authors: michalek je. Sci Rep. 2023 Sep 1;13(1):14360. doi: 10.1038/s41598-023-40751-z. Sci Rep. 2023. PMID: 37658148 Free PMC article.
119 results